Literature DB >> 4617784

Heart preservation with metabolic inhibitor, hypothermia, and hyperbaric oxygenation.

K Todo, S Nakae, J Wada.   

Abstract

The effect of metabolic inhibitor, hypothermia (4 degrees C) and hyperbaric oxygenation (3 atm) on prolonging survival of the canine anoxic heart has been evaluated. Donor hearts were obtained from small mongrel dogs by giving the pre-cooled perfusate of 2 per cent magnesium sulfate (MgSO4), 5 per cent low molecular weight dextran (LMWD) and 2 per cent glucose into the right atrium. Excised hearts were kept at 4 degrees C in a hyperbaric chamber pressurized to 3 atm. After 18 to 48 hours the preserved hearts were transplanted to the neck of recipients by the methods of Marcus. The viability of the preserved hearts were evaluated with functional, biochemical and histologic parameters. Of 29 hearts preserved for 18 to 36 hours, 27 hearts returned to a strong coordinated beat and could maintain function for over 4 hours. Of 5 hearts preserved for 48 hours, 4 showed a coordinated ventricular beat, however, failed to maintain cardiac work over 4 hours. The hearts with 18 to 36 hours storage showed no significant abnormalities on myocardial metabolism and morphology as compared to the control group of the immediately transplanted hearts. The protective action of magnesium is probably related to a number of factors, including metabolic depression and stabilizing effect on membrane permeability of cells to potassium, which would tend to maintain a more normal membrane potential and sub-cellular particles. These studies indicate that viability of the mammalian anoxic hearts can be extended to 36 hours by the combined use of metabolic blockade, hypothermia and hyperbaria suggesting a practical approach to procurement and preservation of cadaver organs.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4617784     DOI: 10.1007/bf02471379

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  16 in total

1.  HEART PRESERVATION IN VITRO WITH HYPERBARIC OXYGENATION AND HYPOTHERMIA.

Authors:  J H BLOCH; W G MANAX; Z EYAL; R C LILLEHEI
Journal:  J Thorac Cardiovasc Surg       Date:  1964-12       Impact factor: 5.209

2.  UTILIZATION OF CHLORPROMAZINE IN HEART STORAGE AND ITS COMBINED USE WITH HYPERBARIC OXYGEN AND HYPOTHERMIA.

Authors:  Z EYAL; R C LILLEHEI; W G MANAX; J H BLOCH
Journal:  Surg Gynecol Obstet       Date:  1965-06

3.  Oxidation reduction in heart muscle. Theoretical and clinical considerations.

Authors:  S GUDBJARNASON; R O HAYDEN; V E WENDT; T B STOCK; R J BING
Journal:  Circulation       Date:  1962-11       Impact factor: 29.690

4.  Metabolic, histologic and histochemical aspects of the homografted heart.

Authors:  R J BING; C CHIBA; A CHRYSOHOU; S GUDBJARNASON; P L WOLF
Journal:  Trans Assoc Am Physicians       Date:  1961

5.  Oxygen transport and utilization in dogs at low body temperatures.

Authors:  W G Bigelow; W K Lindsay
Journal:  Am J Physiol       Date:  1950-01

6.  Extended survival of the normothermic anoxic heart with metabolic inhibitors.

Authors:  S Nakae; W R Webb; K E Salyer; M O Unal; W A Cook; R P Dodds; G T Williams
Journal:  Ann Thorac Surg       Date:  1967-01       Impact factor: 4.330

Review 7.  Transplantation of the small bowel and stomach.

Authors:  W G Manax; G W Lyons; R C Lillehei
Journal:  Adv Surg       Date:  1966

8.  Acute orthotopic transplantation of hearts stored for 72 hours.

Authors:  E Proctor; G Matthews; J Archibald
Journal:  Thorax       Date:  1971-01       Impact factor: 9.139

9.  Suspended animation of the heart with metabolic inhibitors. Effect of magnesium sulfate or fluoride and adrenochrome in rats.

Authors:  W R Webb; R P Dodds; M O Unal; A M Karow; W A Cook; C R Daniel
Journal:  Ann Surg       Date:  1966-09       Impact factor: 12.969

10.  A STUDY OF THE ADENOSINE TRIPHOSPHATASE ACTIVITY OF MYOSIN AND ACTOMYOSIN.

Authors:  W F Mommaerts; K Seraidarian
Journal:  J Gen Physiol       Date:  1947-05-20       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.